NEW YORK (GenomeWeb News) – The University of Cambridge, Genomics England, and Illumina plan to sequence 10,000 whole genomes of children and adults with rare genetic diseases over three years, the organizations said today.

Under the study, called the Rare Diseases Genomes Project, researchers at the University of Cambridge will work with a team at Illumina led by Chief Scientist David Bentley to develop a workflow and processes for bringing routine clinical whole-genome sequencing to patients. Illumina will contribute the sequencing data using its own technology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.